Stubbe, Beuning named ACS fellows; Okáľová receives UGA scholarship
Stubbe, Beuning named ACS Fellows
The American Chemical Society has announced its . ACS fellows are recognized for outstanding achievements and contributions in science and for their service to the scientific community. This year’s inductees include two 91Ӱmembers.

, a professor at Northeastern University and recently named chair of that university’s department of chemistry and chemical biology, studies the structure–function relationships and catalytic mechanisms of enzymes involved in DNA metabolism and cells’ tolerance for DNA damage. Her lab is particularly interested in a family of E. coli DNA polymerases that can synthesize new DNA strands even if there is damage in the template DNA, called the Y family. They also work on prediction of protein functions, and protein engineering, in a longtime collaboration with Northeastern colleague Mary Jo Ondrechen. Beuning is highly involved in undergraduate and graduate education and faculty professional development, and serves on the ACS Committee on Economic and Professional Affairs.

, Novartis professor of chemistry and biology, emerita, at the Massachusetts Institute of Technology, studies enzymatic reaction mechanisms including ribonucleotide reductases that catalyze the conversion of RNA building blocks to DNA building blocks in all organisms. Her studies have established the importance of controlled radical reactions in biology. Stubbe and her many collaborators have uncovered how gemcitabine, a clinically used cancer therapeutic, stoichiometrically inhibits these enzymes and how the natural-product therapeutic bleomycin cleaves DNA via radical mediated mechanisms. Among her many honors, Stubbe was awarded the National Medal of Science in 2009, and earlier this year she received the Priestly Medal, the highest honor that the ACS awards.
Okáľová receives UGA scholarship
Jennifer Okáľová, an undergraduate at the University of Georgia, was recently awarded the UGA College of Pharmacy’s Richard A. Bryan Scholarship for High Academic Achievement and Excellence in Research.

Okáľová, who is set to graduate in spring 2021 with a degree in pharmaceutical sciences, has worked for more than two years in Neil Grimsey’s lab alongside a graduate student, Jeremy Burton, to develop a fluorescence biosensor platform to assess the spatiotemporal activation of atypical p38 signaling in living cells.
The $1,000 Bryan Scholarship is awarded annually to an undergraduate researcher in the pharmaceutical sciences program. Okáľová also received UGA’s Center for Undergraduate Research Opportunites, or CURO, Summer Research Fellowship. She won an Experimental Biology 2020 Travel Award to travel to San Diego, but the in-person conference was canceled due to the COVID-19 outbreak.
“Research is my passion,” Okáľová said. “Being both a student and research assistant has shown me that science is more than a career path, it is a lifestyle. I am excited to be applying to graduate programs to start a Ph.D. program in fall 2021 so I can continue my journey.”
Enjoy reading 91ӰToday?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from 91ӰToday
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in People
People highlights or most popular articles

In memoriam: Ralph G. Yount
He was a professor emeritus of chemistry and biochemistry at Washington State University and an 91Ӱmember for 58 years.

From dust to discovery
From makeshift classrooms in Uganda to postdoctoral research in Chicago, MOSAIC scholar Elizabeth Kaweesa builds a legacy in women’s health.

Fliesler wins scientific and ethical awards
He is being honored by the University at Buffalo and the American Oil Chemists' Society for his scientific achievements and ethical integrity.

Hope for a cure hangs on research
Amid drastic proposed cuts to biomedical research, rare disease families like Hailey Adkisson’s fight for survival and hope. Without funding, science can’t “catch up” to help the patients who need it most.

Before we’ve lost what we can’t rebuild: Hope for prion disease
Sonia Vallabh and Eric Minikel, a husband-and-wife team racing to cure prion disease, helped develop ION717, an antisense oligonucleotide treatment now in clinical trials. Their mission is personal — and just getting started.

91Ӱmembers recognized as Allen investigators
Ileana Cristea, Sarah Cohen, Itay Budin and Christopher Obara are among 14 researchers selected as Allen Distinguished Investigators by the Paul G. Allen Family Foundation.